Want to see DE:M3V full AI Analyst Report?
MeVis Medical Solutions (M3V) Financial Statements
MeVis Medical Solutions Financial Overview
MeVis Medical Solutions's market cap is currently $37.13M. The company's EPS TTM is $0.76; its P/E ratio is 26.84; and it has a dividend yield of 4.66%. MeVis Medical Solutions is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
| Sep 25 | Sep 24 | Sep 23 | Sep 22 | Sep 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 16.06M | $ 16.97M | $ 17.34M | $ 18.76M | $ 16.21M |
| Gross Profit | $ 15.69M | $ 16.48M | $ 7.00M | $ 18.02M | $ 15.78M |
| Operating Income | $ 2.34M | $ 4.00M | $ 6.44M | $ 6.29M | $ 6.45M |
| EBITDA | $ 3.43M | $ 4.82M | $ 5.17M | $ 7.97M | $ 4.77M |
| Net Income | $ 3.17M | $ 4.56M | $ 4.92M | $ 7.79M | $ 4.55M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 6.52M | $ 6.53M | $ 7.74M | $ 9.32M | $ 7.62M |
| Total Assets | $ 25.89M | $ 26.48M | $ 28.05M | $ 31.20M | $ 27.53M |
| Total Debt | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Net Debt | $ -6.52M | $ -6.53M | $ -7.74M | $ -9.32M | $ -7.62M |
| Total Liabilities | $ 8.06M | $ 8.66M | $ 10.23M | $ 13.38M | $ 9.71M |
| Stockholders' Equity | $ 17.83M | $ 17.83M | $ 17.83M | $ 17.83M | $ 17.83M |
| Cash Flow | |||||
| Free Cash Flow | $ 3.74M | $ 2.84M | $ 5.77M | $ 4.72M | $ 9.08M |
| Operating Cash Flow | $ 3.88M | $ 3.15M | $ 5.85M | $ 4.86M | $ 9.13M |
| Investing Cash Flow | $ 945.46K | $ 906.80K | $ 989.98K | $ 58.66K | $ 111.63K |
| Financing Cash Flow | $ -4.56M | $ -4.92M | $ -7.79M | $ -4.55M | $ -5.70M |
Currency in EUR